NEWS & EVENTS
Science Highlights • March 28, 2006
Most neurological damage occurs to fetuses prior to the onset of labor. Developing a screening tool to detect this damage is one of the goals of a new fetal monitoring system developed by researchers at the University of Arkansas for Medical Sciences in Little Rock.
Science Highlights • February 9, 2006
The success of minimally invasive procedures depends in part on novel imaging systems. A hybrid X-ray/MRI system combines the best of both technologies and eliminates the need to shuttle patients back and forth between different imaging systems.
Science Highlights • December 22, 2005
A new technique combining flexible microbubbles and optical imaging may enable researchers to discover dormant metastatic cancer cells as well as improve tumor staging and classification.
Science Highlights • September 16, 2005
A new method for delivering drugs directly to diseased tissue may increase the effectiveness of chemotherapy in brain tumors and reduce its toxic effect on healthy cells.
Science Highlights • August 11, 2005
An innovative functional magnetic resonance imaging technique reveals unusually low activity levels in the brain of teens with attention deficit hyperactivity disorder (ADHD), a reading disorder, or both conditions.
Science Highlights • July 13, 2005
A modified magnetic resonance imaging (MRI) technique that can assess a patient in less than 20 minutes and does not require injection of specialized dye may help identify cancers and track the effectiveness of treatment.
Science Highlights • June 10, 2005
Innovative synthetic tissue scaffolds that transport molecular signals directly to ailing cells such as those in the brain or spinal cord may eventually provide a way to regenerate damaged neurons and restore junctions between nerve fibers lost in paralysis.
Science Highlights • April 29, 2005
A new brain database and atlas may answer some of the most vexing questions about how the brain works. Image warping techniques allow investigators to compare individual brains with populations of healthy or diseased brains.
Science Highlights • March 30, 2005
Synchrotron X-ray footprinting coupled with 3-D computer modeling yields unprecedented insight into the molecular interaction of two viral molecules responsible for causing colds and pinkeye.
Science Highlights • March 1, 2005
Transdermal patches—medicated adhesive pads placed on the skin that release drugs gradually for up to a week—have been available in the U.S. for more than 20 years. The first transdermal patch, approved by the U.S. Food and Drug Administration in 1979, delivered scopolamine to treat motion sickness. Since then, more than 35 transdermal patch products have been approved. Examples include the nicotine patch that helps people quit smoking, the lidocaine patch for relieving pain, and a patch containing hormone derivatives for preventing pregnancy.